人工肝支持治疗下乙型肝炎相关慢加急性肝功能衰竭患者的近期预后分析

王贤; 王少扬; 黄德东; 陈剑; 陈德良

doi:10.3969/j.issn.1001-5256.2014.04.020

人工肝支持治疗下乙型肝炎相关慢加急性肝功能衰竭患者的近期预后分析

DOI: 10.3969/j.issn.1001-5256.2014.04.020

南京军区福州总医院肝胆病中心感染科

基金项目:

国家青年自然科学基金项目(31200655)；

详细信息

中图分类号: R575.3
计量
- 文章访问数: 325
- HTML全文浏览量: 16
- PDF下载量: 105
- 被引次数: 6
出版历程
- 出版日期: 2014-04-20

Analysis of short-term prognostic factors in patients with HBV-related acute-on-chronic liver failure treated with artificial liver support system

Department of Infectious Diseases, Center for Hepatobiliary Disease, Fuzhou General Hospital of Nanjing Military Region

Research funding:

摘要

摘要:
目的探讨人工肝治疗下乙型肝炎相关慢加急性肝功能衰竭的近期预后及其与HBeAg等各项临床检验指标之间的关系。为及时、准确判定乙型肝炎相关慢加急性肝功能衰竭预后提供参考。方法回顾性分析81例经体外人工肝支持及内科综合治疗乙型肝炎相关慢加急性肝功能衰竭患者(其中HBeAg阴性者55例,HBeAg阳性者26例)临床资料,分析不同HBeAg状态患者预后及各项检验指标(ALT、AST、TBil、白蛋白、前白蛋白、胆碱酯酶、凝血时间国际标准化比值、血氨、甲胎蛋白等)的差异。2组间比较采用卡方或非参数检验进行分析。结果 HBeAg阳性与阴性乙型肝炎相关慢加急性肝功能衰竭患者预后无明显差异(P=0.158),检验指标中前白蛋白、甲胎蛋白、国际标准化比值在治疗有效组与无效组之间有明显差异(P<0.000 1,P=0.000 5,P<0.000 1),进一步做ROC曲线,AUC值:前白蛋白,0.875;甲胎蛋白,0.795;国际标准化比值,0.792。结论人工肝支持治疗下HBeAg阳性与阴性乙型肝炎相关慢加急性肝功能衰竭患者预后无明显差异,前白蛋白、甲胎蛋白、凝血时间国际标准化比值作为乙型肝炎相...
- 肝功能衰竭 /
- 肝炎,乙型 /
- 血浆置换
Abstract:
Objective To investigate the short- term prognosis in hepatitis B virus (HBV) - related acute- on- chronic liver failure (ACLF) treated with artificial liver support system (ALSS) and its relationship with clinical indices including HBeAg and to provide reference for the timely, accurate prognostic evaluation of HBV- related ACLF.Methods A retrospective analysis was performed on the clinical data of 81 patients with HBV- related ACLF (55 HBeAg- negative cases and 26 HBeAg- positive cases) who received ALSS treatment and comprehensive medical treatment.The HBeAg- negative cases and HBeAg- positive cases were compared in terms of treatment outcome and laboratory indices including alanine aminotransferase, total bilirubin, albumin, prealbumin (PA) , cholinesterase, international normalized ratio (INR) , blood ammonia, and alpha- fetoprotein (AFP) .Comparison between two groups was made by chi- square test or non- parametric test.Results There was no significant difference in treatment outcome between the HBeAg- negative cases and HBeAg- positive cases (P = 0.158) .There were significant differences in PA, AFP, and INR between the patients with response to treatment and those without response to treatment (P < 0.000 1, P = 0.000 5, and P < 0.000 1) .The receiver operating characteristic (ROC) curves of PA, AFP, and INR were drawn, and their areas under the ROC curves were 0.875, 0.795, and 0.792, respectively.Conclusion There is no significant difference in treatment outcome between HBeAg- positive and HBeAg- negative patients with HBV- related ACLF treated with ALSS.PA, AFP, and INR can be used as accurate indices for prognostic evaluation of HBV- related ACLF.
- liver failure /
- hepatitis B /
- plasma exchange

HTML全文

参考文献(8)

[1]KATOONIZADEH A, LALEMAN W, VERSLYPE C, et al.Early features of acute-on-chronic alcoholic liver failure:a prospectivecohort study[J].Gut, 2010, 59 (11) :1561-1569.

[2]Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA.Guideline for diagnosis and treatment of liver failure[J/CD].Chin J Transplant:Electronic Edition, 2013, 7 (1) :48-56. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J/CD].中华移植杂志:电子版, 2013, 7 (1) :48-56.

[3]ZHANG AM, XIN SJ.Virus infection and liver failure[J].J Clin Hepatol, 2012, 28 (10) :729-731. (in Chinese) 张爱民, 辛绍杰.病毒感染与肝功能衰竭[J].临床肝胆病杂志, 2012, 28 (10) :729-731.

[4]ZHANG WH, JIA WL, ZHOU ZR, et al.Investigation on the method and safety of the non-heparinized plasma exchange therapy in treating patients with hepatic failure[J].J Clin Hepatol, 2012, 28 (1) :50-52. (in Chinese) 张文华, 贾文玲, 周子英, 等.无肝素血浆置换治疗肝功能衰竭的方法及安全性探讨[J].临床肝胆病杂志, 2012, 28 (1) :50-52.

[5]BAHIRWANI R, SHAKED O, BEWTRA M, et al.Acute-on-chronic liver failure before liver transplantation:impacton posttransplant outcomes[J].Transplantation, 2011, 92 (8) :952-957.

[6]MO ZS, LI XH, LEI ZY, et al.Comparison of the clinical features of HBV induced acute-on-chronic liver failure with diferent HBeAg status[J].China Mod Med, 2012, 19 (23) :74-78. (in Chinese) 莫志硕, 李新华, 雷姿颖, 等.不同HBeAg状态乙型肝炎慢加急性肝衰竭的临床特点比较[J].中国当代医药, 2012, 19 (23) :74-78.

[7]NIE XH, XIANG HL, HAN T, et al.Prediction of prealbumin rate for liver failure patients prognosis[J].Shandong Med J, 2012, 52 (44) :56-59. (in Chinese) 聂新华, 向慧玲, 韩涛, 等.前白蛋白变化率对肝衰竭预后的预测作用[J].山东医药, 2012, 52 (44) :56-59.

[8]SCHMIDT LE, DALHOFF K.Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury[J].Hepatology, 2005, 41 (1) :26-31.

施引文献

期刊类型引用(5)

1.	田亚兰，王瑞芬，李彩玲，张长江，崔玲玲，范梦琳，王艳. 食管癌患者血硒水平Meta分析. 河南预防医学杂志. 2021(11): 834-839 . 百度学术
2.	吴志国，曾荣耀，叶禧珑，陈志钊. 生长因子在原发性肝细胞癌中的表达及与预后的相关性. 中国慢性病预防与控制. 2019(11): 859-863 . 百度学术
3.	赵燕颖，王秀岩，秦国涛，孙远杰，刘志忠，李然伟. 血管内皮生长因子165b对人肝癌HepG_2细胞生物学特性的影响. 吉林大学学报(医学版). 2018(01): 101-105 . 百度学术
4.	游宇来，邓明华，龚建平. 2型糖尿病与肝细胞癌的关系. 临床肝胆病杂志. 2018(08): 1793-1796 . 本站查看
5.	夏念信，邱宝安，王敬晗，刘鹏，祝建勇，赵文超，安阳. 化疗联合槐耳颗粒对原发性肝癌术后复发/转移患者预后影响研究. 临床军医杂志. 2017(09): 887-890 . 百度学术